Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

Clinical trial NCT01384292 · TERMINATED

Trial details

NCT number: NCT01384292
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Opioid-Induced Constipation

Start date: 2011-06-01
Primary completion: 2012-09-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.